1-beta-d-arabinofuranosylcytosine 5'-monophosphate has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyer, SH; Craigo, W; Erion, MD; Esterbrook, J; Gómez-Galeno, JE; Jiang, H; MacKenna, DA; Reddy, KR; Sun, Z; Ugarkar, BG | 1 |
1 other study(ies) available for 1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Hepatocellular Carcinoma
Article | Year |
---|---|
Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Prodrugs; Rats; Tissue Distribution | 2006 |